Yatharth Hospital & Trauma Care Services (YATHARTH) Stock Overview
Owns and operates super-specialty hospitals in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for YATHARTH from our risk checks.
YATHARTH Community Fair Values
Create NarrativeSee what 26 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Yatharth Hospital & Trauma Care Services Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹857.00 |
| 52 Week High | ₹889.90 |
| 52 Week Low | ₹514.50 |
| Beta | 0.99 |
| 1 Month Change | 4.44% |
| 3 Month Change | 32.29% |
| 1 Year Change | 62.97% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 156.70% |
Recent News & Updates
Narrative Update • Jun 10
YATHARTH: Gurugram Sector 40 Hospital Acquisition Will Support Long Term Upside View
Analysts now place Yatharth Hospital & Trauma Care Services' price target at ₹986, compared with the prior ₹941.67. This reflects updated assumptions around fair value and a slightly higher future P/E multiple, while keeping revenue growth, profit margin and discount rate largely consistent.Analysis Article • May 28
Yatharth Hospital & Trauma Care Services Limited Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ) filed its...Narrative Update • May 26
YATHARTH: Upcoming Gurugram Hospital Acquisition Will Support Long Term Upside View
Analysts have kept their price target for Yatharth Hospital & Trauma Care Services steady at ₹941.67, citing updated assumptions that now combine slightly adjusted growth expectations with a higher profit margin outlook and a lower future P/E multiple. What's in the News The board has scheduled a meeting on May 25, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).Recent updates
Narrative Update • Jun 10
YATHARTH: Gurugram Sector 40 Hospital Acquisition Will Support Long Term Upside View
Analysts now place Yatharth Hospital & Trauma Care Services' price target at ₹986, compared with the prior ₹941.67. This reflects updated assumptions around fair value and a slightly higher future P/E multiple, while keeping revenue growth, profit margin and discount rate largely consistent.Analysis Article • May 28
Yatharth Hospital & Trauma Care Services Limited Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ) filed its...Narrative Update • May 26
YATHARTH: Upcoming Gurugram Hospital Acquisition Will Support Long Term Upside View
Analysts have kept their price target for Yatharth Hospital & Trauma Care Services steady at ₹941.67, citing updated assumptions that now combine slightly adjusted growth expectations with a higher profit margin outlook and a lower future P/E multiple. What's in the News The board has scheduled a meeting on May 25, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).Narrative Update • May 05
YATHARTH: Upcoming Special Meeting Will Support Long Term Upside View
Analysts kept their price target for Yatharth Hospital & Trauma Care Services steady at ₹941.67, citing unchanged assumptions around the discount rate, expected revenue growth, profit margin, and future P/E. What's in the News The company has scheduled a Special or Extraordinary Shareholders Meeting for May 12, 2026, to be conducted via postal ballot in India (Key Developments) The postal ballot format means you will not need to attend in person, but participation will still depend on completing and returning voting materials on time (Key Developments) The meeting outcome could include decisions on corporate actions that affect share structure or governance, so it may be worth tracking the official notice and resolutions once released (Key Developments) Valuation Changes Fair Value: ₹941.67 fair value estimate remains unchanged, with no adjustment in the latest update.Narrative Update • Apr 20
YATHARTH: Upcoming Earnings And Shareholder Meetings Will Reinforce Long Term Upside View
Analysts have kept their price target for Yatharth Hospital & Trauma Care Services steady at ₹941.67 per share, reflecting unchanged assumptions around the discount rate, revenue growth, profit margin and future P/E expectations. What's in the News Board meeting scheduled for Feb 05, 2026 at 13:10 Indian Standard Time to consider and approve unaudited standalone and consolidated financial results for the quarter ended Dec 31, 2025 (company filing).Narrative Update • Apr 05
YATHARTH: Upcoming Results Meeting Will Support Long Term Upside View
Analysts have kept their price target for Yatharth Hospital & Trauma Care Services unchanged at ₹941.67, reflecting consistent assumptions on discount rate, revenue growth, profit margin and future P/E. What's in the News Board meeting scheduled for Feb 05, 2026, at 13:10 Indian Standard Time.Narrative Update • Mar 21
YATHARTH: Upcoming Results Meeting Will Support Long Term Upside View
Analysts have kept their price target for Yatharth Hospital & Trauma Care Services unchanged at about ₹942 per share, reflecting consistent assumptions on revenue growth, profit margins and future P/E multiples. What's in the News Board meeting scheduled on Feb 05, 2026, at 13:10 Indian Standard Time to consider and approve unaudited standalone and consolidated financial results for the quarter ended Dec 31, 2025 (company filing).Narrative Update • Mar 05
YATHARTH: Upcoming Board And Shareholder Meetings Will Reinforce Long Term Upside Confidence
Analysts have nudged up their price target for Yatharth Hospital & Trauma Care Services from ₹931.25 to about ₹941.67, reflecting updated assumptions around revenue growth, profit margins and the forward P/E multiple, while keeping the discount rate unchanged. What's in the News Board meeting scheduled for Feb 05, 2026 at 13:10 Indian Standard Time to consider and approve unaudited standalone and consolidated financial results for the quarter ended Dec 31, 2025 (Key Developments).Narrative Update • Feb 19
YATHARTH: Upcoming Meetings Will Support Confidence In Long Term Upside Potential
Analysts have trimmed their price target on Yatharth Hospital & Trauma Care Services from ₹935 to ₹931.25, reflecting updated assumptions on revenue growth, profit margins and future P/E multiples while keeping the discount rate unchanged. What's in the News Board meeting scheduled for Feb 05, 2026, at 13:10 Indian Standard Time to consider and approve the unaudited standalone and consolidated financial results for the quarter ended Dec 31, 2025 (Key Developments).Analysis Article • Feb 08
Yatharth Hospital & Trauma Care Services Limited Just Beat Revenue By 14%: Here's What Analysts Think Will Happen Next
It's been a good week for Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ) shareholders, because the...Narrative Update • Feb 05
YATHARTH: Upcoming Board And Shareholder Meetings Will Support Future Upside Potential
Analysts have kept their fair value estimate for Yatharth Hospital & Trauma Care Services steady at ₹935, while making only small tweaks to assumptions such as discount rate and future P/E. This reflects refined modelling rather than a change in overall view.Analysis Article • Feb 02
Yatharth Hospital & Trauma Care Services Limited's (NSE:YATHARTH) Intrinsic Value Is Potentially 24% Below Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Yatharth Hospital & Trauma Care Services fair value estimate...Narrative Update • Jan 22
YATHARTH: Upcoming Board Review Will Support Future Upside Potential
Analysts have kept their fair value estimate for Yatharth Hospital & Trauma Care Services steady at ₹935, reflecting unchanged assumptions on the discount rate, revenue growth of 33.17%, profit margin of 15.48% and a future P/E of 43.57x. What's in the News Board meeting scheduled for November 13, 2025, to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2025 (company filing).Analysis Article • Jan 12
We Think Yatharth Hospital & Trauma Care Services (NSE:YATHARTH) Can Stay On Top Of Its Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Narrative Update • Jan 08
YATHARTH: Steady Assumptions And Upcoming Meetings Will Support Future Upside
Analysts have kept their fair value estimate for Yatharth Hospital & Trauma Care Services unchanged at ₹935.0 per share, reflecting consistent assumptions around revenue growth, profit margins and future P/E in their updated work. What's in the News Board meeting scheduled for November 13, 2025, to consider and approve unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2025 (company filing).Narrative Update • Dec 17
YATHARTH: New Auditor Appointment Will Support Profits And Future Upside
Analysts have nudged their price target for Yatharth Hospital & Trauma Care Services slightly lower, from ₹940 to ₹935. This reflects modestly softer assumptions on revenue growth and profit margins, even as they factor in a somewhat higher future valuation multiple.Narrative Update • Dec 02
YATHARTH: Shantived Acquisition And Auditor Change Will Sustain Profit Margins
Analysts have maintained their fair value estimate for Yatharth Hospital & Trauma Care Services at ₹940, citing stable growth projections and consistent profit margins as the basis for their decision. What's in the News The board meeting is scheduled for November 13, 2025, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2025 (Board Meeting Agenda).Narrative Update • Nov 18
YATHARTH: Acquisition Of Shantived Will Drive Profit Margins Higher This Year
Analysts have raised their price target for Yatharth Hospital & Trauma Care Services from ₹835 to ₹940, citing improved revenue growth and stronger profit margins as key drivers behind the upward revision. What's in the News A board meeting is scheduled for November 13, 2025, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2025.Analysis Article • Nov 17
Earnings Update: Here's Why Analysts Just Lifted Their Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH) Price Target To ₹835
Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ) came out with its quarterly results last week, and we...Analysis Article • Nov 12
Yatharth Hospital & Trauma Care Services Limited's (NSE:YATHARTH) Earnings Haven't Escaped The Attention Of Investors
Yatharth Hospital & Trauma Care Services Limited's ( NSE:YATHARTH ) price-to-earnings (or "P/E") ratio of 51.4x might...Narrative Update • Sep 19
India's Urbanization And Demographics Will Drive Healthcare Expansion
Analysts have revised their outlook upward for Yatharth Hospital & Trauma Care Services, driven by higher forecasts for both future P/E and revenue growth, resulting in an increased consensus price target from ₹780.00 to ₹835.00. What's in the News Board approved entering a binding term sheet to acquire 100% of Shantived Institute of Medical Sciences at an enterprise value of INR 2,600 million.Analysis Article • Sep 05
Is Now An Opportune Moment To Examine Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH)?
Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ), is not the largest company out there, but it...Narrative Update • Aug 07
India's Urbanization And Demographics Will Drive Healthcare Expansion
The consensus price target for Yatharth Hospital & Trauma Care Services has been raised to ₹633.33, reflecting increased valuation expectations despite a lower net profit margin and a higher future P/E multiple. What's in the News Inaugurated a new 300-bed super speciality hospital in Model Town, New Delhi, expanding group capacity to over 2,300 beds across 7 hospitals.Analysis Article • Jul 22
Yatharth Hospital & Trauma Care Services Limited's (NSE:YATHARTH) 25% Price Boost Is Out Of Tune With Earnings
Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ) shareholders have had their patience rewarded with a...Analysis Article • Jun 03
Yatharth Hospital & Trauma Care Services' (NSE:YATHARTH) Solid Earnings May Rest On Weak Foundations
Yatharth Hospital & Trauma Care Services Limited's ( NSE:YATHARTH ) healthy profit numbers didn't contain any surprises...Analysis Article • May 30
Earnings Beat: Yatharth Hospital & Trauma Care Services Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
As you might know, Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ) just kicked off its latest yearly...Analysis Article • May 18
Calculating The Intrinsic Value Of Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH)
Key Insights The projected fair value for Yatharth Hospital & Trauma Care Services is ₹462 based on 2 Stage Free Cash...
New Narrative • May 02
New Delhi And Faridabad Hospitals Will Elevate Patient Care
Recent acquisitions and technological advancements could drive revenue growth through increased bed capacity, high-value services, and pricing power in specialized procedures.Analysis Article • Apr 04
What Yatharth Hospital & Trauma Care Services Limited's (NSE:YATHARTH) 27% Share Price Gain Is Not Telling You
Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ) shareholders are no doubt pleased to see that the...Analysis Article • Jan 30
Yatharth Hospital & Trauma Care Services Limited Just Beat Revenue By 6.6%: Here's What Analysts Think Will Happen Next
Shareholders might have noticed that Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ) filed its...Analysis Article • Jan 29
Investors Give Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH) Shares A 30% Hiding
Unfortunately for some shareholders, the Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ) share price...Analysis Article • Jan 14
Is Now The Time To Put Yatharth Hospital & Trauma Care Services (NSE:YATHARTH) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Analysis Article • Nov 10
Here's What Analysts Are Forecasting For Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH) After Its Second-Quarter Results
Last week, you might have seen that Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ) released its...Analysis Article • Nov 09
Yatharth Hospital & Trauma Care Services (NSE:YATHARTH) Is Doing The Right Things To Multiply Its Share Price
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Analysis Article • Sep 16
Here's Why Yatharth Hospital & Trauma Care Services (NSE:YATHARTH) Has Caught The Eye Of Investors
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Analysis Article • May 31
Yatharth Hospital & Trauma Care Services' (NSE:YATHARTH) Earnings Are Weaker Than They Seem
Investors were disappointed with Yatharth Hospital & Trauma Care Services Limited's ( NSE:YATHARTH ) earnings, despite...Analysis Article • Apr 13
Optimistic Investors Push Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH) Shares Up 26% But Growth Is Lacking
Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ) shareholders have had their patience rewarded with a...Analysis Article • Feb 24
Earnings Not Telling The Story For Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH) After Shares Rise 25%
Yatharth Hospital & Trauma Care Services Limited ( NSE:YATHARTH ) shares have had a really impressive month, gaining...Shareholder Returns
| YATHARTH | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 4.3% | 2.2% | 0.6% |
| 1Y | 63.0% | 12.8% | -0.2% |
Return vs Industry: YATHARTH exceeded the Indian Healthcare industry which returned 12.8% over the past year.
Return vs Market: YATHARTH exceeded the Indian Market which returned -0.2% over the past year.
Price Volatility
| YATHARTH volatility | |
|---|---|
| YATHARTH Average Weekly Movement | 5.7% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.5% |
Stable Share Price: YATHARTH has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: YATHARTH's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 4,895 | Amit Singh | www.yatharthhospitals.com |
Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant. It also provides services in the areas of GI surgery and liver transplant, robotic surgery, kidney transplant, IVF and fertility, emergency medicine, ophthalmology, dentistry, psychology and psychiatry, physiotherapy and rehabilitation, anesthesiology, radiology, pathology and laboratory medicine, nutrition and health, interventional spine and pain medicine, neurology, neurosurgery, and cardiovascular and thoracic surgery.
Yatharth Hospital & Trauma Care Services Limited Fundamentals Summary
| YATHARTH fundamental statistics | |
|---|---|
| Market cap | ₹82.22b |
| Earnings (TTM) | ₹1.75b |
| Revenue (TTM) | ₹12.33b |
47.1x
P/E Ratio6.7x
P/S RatioIs YATHARTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YATHARTH income statement (TTM) | |
|---|---|
| Revenue | ₹12.33b |
| Cost of Revenue | ₹4.69b |
| Gross Profit | ₹7.64b |
| Other Expenses | ₹5.88b |
| Earnings | ₹1.75b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 18.20 |
| Gross Margin | 61.95% |
| Net Profit Margin | 14.22% |
| Debt/Equity Ratio | 14.0% |
How did YATHARTH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/24 11:48 |
| End of Day Share Price | 2026/06/24 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Yatharth Hospital & Trauma Care Services Limited is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | BP Wealth Management Private Limited |
| Sumit Gupta | Centrum Broking Limited |
| Akshaya Shinde | Centrum Broking Limited |